Table 2.
Kaplan–Meier survival analyses and log-rank tests
Variables | Cases (n) | Survival months (Mean ± SD) | 5-year OS (%) | P-value |
---|---|---|---|---|
Gender | 0.913 | |||
Female | 23 | 73.80±6.72 | 65.5 | |
Male | 64 | 76.11±3.42 | 82.3 | |
Age (years) | 0.010a | |||
≤58 | 41 | 84.19±3.13 | 96.0 | |
>58 | 46 | 67.29±4.77 | 61.1 | |
Location | 0.017a | |||
Ascending | 33 | 64.87±4.62 | 62.7 | |
Transverse | 13 | 68.52±9.78 | 64.3 | |
Descending/sigmoid | 41 | 85.07±3.35 | 95.5 | |
Differentiation | <0.001a | |||
Poor | 17 | 67.87±5.93 | 77.5 | |
Moderate | 66 | 80.05±3.45 | 83.9 | |
Well | 4 | 42.67±2.96 | 0.00 | |
Tumor size (diameter, cm) | 0.920 | |||
≤5.0 | 56 | 74.85±4.05 | 73.3 | |
>5.0 | 31 | 75.19±4.18 | 85.9 | |
Invasion depth | 0.253 | |||
T1–T2 | 36 | 81.34±3.03 | 90.9 | |
T3–T4 | 51 | 72.19±4.85 | 68.5 | |
Lymph node metastasis | 0.011a | |||
Negative | 39 | 86.59±4.02 | 90.2 | |
Positive | 48 | 69.10±4.05 | 69.7 | |
PYK2 expression | 0.001a | |||
Low | 44 | 84.61±3.57 | 96.6 | |
High | 43 | 64.42±4.49 | 57.6 |
Note:
Statistically significant (P<0.05).